palexia 20 mg/ml oral solution
grünenthal ltd - tapentadol hydrochloride - oral solution - 20 mg/ml - other opioids
palexia 4 mg/ml oral solution
grunenthal pharma ltd - tapentadol hydrochloride - oral solution - 4 milligram(s)/millilitre - other opioids; tapentadol
palexia 20 mg/ml oral solution
grunenthal pharma ltd - tapentadol hydrochloride - oral solution - 20 milligram(s)/millilitre - other opioids; tapentadol
palexia 4mg/ml oral solution
grunenthal gmbh zieglerstrasse 6, 52078 aachen, germany - tapentadol - oral solution - tapentadol 4 mg/ml - analgesics
palexia 20mg/ml oral solution
grunenthal gmbh zieglerstrasse 6, 52078 aachen, germany - tapentadol - oral solution - tapentadol 20 mg/ml - analgesics
selincro
h. lundbeck a/s - nalmefene hydrochloride dihydrate - alcohol-related disorders - drugs used in alcohol dependence - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking-risk level (see section 5.1), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drinking-risk level two weeks after initial assessment.
selincro 18mg tablets
lundbeck ltd - nalmefene hydrochloride - tablet - 18mg
selincro 18 mg
lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.
selincro 18 mg
lundbeck israel ltd. - nalmefene as hydrochloride dihydrate - film coated tablets - nalmefene as hydrochloride dihydrate 18.06 mg - nalmefene - selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence who have a high drinking risk level (drl), without physical withdrawal symptoms and who do not require immediate detoxification.selincro should only be prescribed in conjunction with continuous psychosocial support focused on treatment adherence and reducing alcohol consumption.selincro should be initiated only in patients who continue to have a high drl two weeks after initial assessment.
caleflunix injection
dechra veterinary products (australia) pty. ltd. - flunixin as flunixin meglumine - parenteral liquid/solution/suspension - flunixin as flunixin meglumine benzene active 50.0 mg/ml - musculoskeletal system - cattle | dog | horse | pigs | beef | bitch | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | castra - analgesic | anti-inflammatory agent | antiprostaglandin | antipyretic | non steroidal | antipyretic | bone soreness | bruising | bursitis | colic | inflammatory rheumatic arthrit | joint disease | ligament sprains | muscle relaxant | muscle soreness | osteoarthritis | platelet activity | rheumatism | sedative | spasmolytic | sprains | strains | tendon sprains | traumatic swelling